Search - tctmd.com

Displaying 561 - 580 of 640

Sort: Relevancy | Date

News Daily News

AHA Scientific Statement Highlights Sex Disparities in CV Risk Among Diabetic Patients

L.A. McKeown

December 09, 2015

News Daily News

Statin Therapy Reduces Influenza Vaccine Effectiveness, Studies Suggest

Yael L. Maxwell

November 03, 2015

News Daily News

年轻女性 STEMI 患者在院内死亡的可能性高于男性

L.A. McKeown

October 28, 2015

News Daily News

Younger Women With STEMI More Likely Than Men to Die In-Hospital

L.A. McKeown

October 28, 2015

News Daily News

Younger Women With STEMI More Likely Than Men to Die In-Hospital

L.A. McKeown

October 28, 2015

News Daily News

Guideline Update Boosts Nonculprit PCI, Knocks Down Aspiration Thrombectomy

Todd Neale

October 26, 2015

News Daily News

Goodbye BMS? New DAPT Analysis Shows Less Stent Thrombosis With DES

Yael L. Maxwell

October 26, 2015

News Daily News

High-Sensitivity Troponin I Assay May Rule Out MI in Large Number of Patients

Todd Neale

October 13, 2015

News Daily News

No Interplay Between Access Site, Cangrelor Effects in PCI Patients

Caitlin E. Cox

October 06, 2015

News Daily News

Contrary to Expectations, Study Finds No Sex Difference in Coronary Microvascular Dysfunction

Yael L. Maxwell

September 23, 2015

News Industry News

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

September 18, 2015

News Daily News

Registry Charts Trends in Mechanical Circulatory Support During PCI

L.A. McKeown

September 14, 2015

News Daily News

COURAGE Analysis: Patients With Lower Exercise Capacity No More Likely to Benefit from Revascularization

L.A. McKeown

September 09, 2015

News Daily News

Análisis del COURAGE: Los Pacientes con una Menor Capacidad de Hacer Ejercicio No son Más Propensos a Beneficiarse de la Revascularización

L.A. McKeown

September 09, 2015

News Industry News

US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack

September 03, 2015

News Industry News

Researchers Use Quanterix’s Simoa Technology to Detect Early Indicators of Potential Adverse Cardiovascular Outcomes

August 26, 2015

News Daily News

High Troponin T Foretells Poor Outcomes in Patients With Type 2 Diabetes, Stable Heart Disease

Todd Neale

August 17, 2015

News Daily News

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

Yael L. Maxwell

August 12, 2015

News Daily News

Cardiac Rehab After Acute MI Still Underutilized in Older Patients

Yael L. Maxwell

August 07, 2015

News Daily News

Zero Calcium Score Provides 15-Year Mortality ‘Warranty’ for Asymptomatic Patients

August 06, 2015

Advertisement

AHA Scientific Statement Highlights Sex Disparities in CV Risk Among Diabetic Patients

Statin Therapy Reduces Influenza Vaccine Effectiveness, Studies Suggest

年轻女性 STEMI 患者在院内死亡的可能性高于男性

Younger Women With STEMI More Likely Than Men to Die In-Hospital

Younger Women With STEMI More Likely Than Men to Die In-Hospital

Guideline Update Boosts Nonculprit PCI, Knocks Down Aspiration Thrombectomy

Goodbye BMS? New DAPT Analysis Shows Less Stent Thrombosis With DES

High-Sensitivity Troponin I Assay May Rule Out MI in Large Number of Patients

No Interplay Between Access Site, Cangrelor Effects in PCI Patients

Contrary to Expectations, Study Finds No Sex Difference in Coronary Microvascular Dysfunction

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

Registry Charts Trends in Mechanical Circulatory Support During PCI

COURAGE Analysis: Patients With Lower Exercise Capacity No More Likely to Benefit from Revascularization

Análisis del COURAGE: Los Pacientes con una Menor Capacidad de Hacer Ejercicio No son Más Propensos a Beneficiarse de la Revascularización

US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack

Researchers Use Quanterix’s Simoa Technology to Detect Early Indicators of Potential Adverse Cardiovascular Outcomes

High Troponin T Foretells Poor Outcomes in Patients With Type 2 Diabetes, Stable Heart Disease

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

Cardiac Rehab After Acute MI Still Underutilized in Older Patients

Zero Calcium Score Provides 15-Year Mortality ‘Warranty’ for Asymptomatic Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content